Democrats: Lawsuit against Obamacare affects 15M on ACA exchange

A pending lawsuit launched by Republicans is threatening to overturn the Affordable Care Act––and the effects could impact 15 million people, according to a recent report from the ranking member of the House Committee on Oversight and Government Reform Rep. Elijah E. Cummings (D-MD).

Specifically, the lawsuit could strip away protections for pre-existing conditions from the healthcare law, as the Trump Justice Department announced it would not defend the ACA. The Department of Justice is typically tasked with defending laws.

More than 15.6 million in the individual market may lose federal protections against coverage denials or premium increases as a result of their pre-existing conditions, gender or age, according to the report.

Another recent analysis from Avalere Health found that more than 100 million people could be impacted by healthcare laws related to pre-existing conditions.

Republicans have attempted to overturn the ACA in Congress several times over the last two years. The lawsuit, which was launched by 20 Republican state attorneys general and governors, is unlikely to conclude before the midterm elections in November.

“President Trump claims all Republicans support people with pre-existing conditions, but just last year 217 Republican House Members voted to eliminate protections for these individuals,” Cummings said in a statement. “The President’s words––and the words of Republicans in Congress––do not match their actions.”

More than 10 million people who purchase insurance through the individual market have pre-exiting conditions, and 4.8 million have conditions severe enough “that insurers may deny them coverage altogether,” the report estimated.

Individuals with employer-sponsored coverage could also be at risk, as current law prohibits employer-based plans from excluding coverage for pre-existing conditions. Because the Trump administration is not defending that specific provision, employer plans could charge higher prices or exclude coverage for pre-existing conditions to new employees for up to one year if they did not maintain continuous coverage prior to enrolling in the employer’s plan.

More than 151 million people could be at risk of losing this federal protection, the report concluded.

Amy Baxter

Amy joined TriMed Media as a Senior Writer for HealthExec after covering home care for three years. When not writing about all things healthcare, she fulfills her lifelong dream of becoming a pirate by sailing in regattas and enjoying rum. Fun fact: she sailed 333 miles across Lake Michigan in the Chicago Yacht Club "Race to Mackinac."

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.